{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:23:07Z","timestamp":1767705787388},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK 56465"],"award-info":[{"award-number":["P30 DK 56465"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["125006-RSG-13-183-01-CSM","(125006-RSG-13-183-01-CSM"],"award-info":[{"award-number":["125006-RSG-13-183-01-CSM","(125006-RSG-13-183-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA229922","R01 CA193808","1R21CA229922","t P30 CA015704"],"award-info":[{"award-number":["1R21CA229922","R01 CA193808","1R21CA229922","t P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insertional mutagenesis is a powerful means of identifying cancer drivers in animal models. We used the Sleeping Beauty (SB) transposon\/transposase system to identify activated oncogenes in hematologic cancers in wild-type mice and mice that express a stabilized cyclin E protein (termed cyclin ET74AT393A). Cyclin E governs cell division and is misregulated in human cancers. Cyclin ET74AT393A mice develop ineffective erythropoiesis that resembles early-stage human myelodysplastic syndrome, and we sought to identify oncogenes that might cooperate with cyclin E hyperactivity in leukemogenesis. SB activation in hematopoietic precursors caused T-cell leukemia\/lymphomas (T-ALL) and pure red blood cell erythroleukemias (EL). Analysis of &gt;12,000 SB integration sites revealed markedly different oncogene activations in EL and T-ALL: <jats:italic>Notch1<\/jats:italic> and <jats:italic>Ikaros<\/jats:italic> were most common in T-ALL, whereas ETS transcription factors (<jats:italic>Erg<\/jats:italic> and <jats:italic>Ets1<\/jats:italic>) were targeted in most ELs. Cyclin E status did not impact leukemogenesis or oncogene activations. Whereas most SB insertions were lost during culture of EL cell lines, <jats:italic>Erg<\/jats:italic> insertions were retained, indicating Erg\u2019s key role in these neoplasms. Surprisingly, cyclin ET74AT393A conferred growth factor independence and altered Erg-dependent differentiation in EL cell lines. These studies provide new molecular insights into erythroid leukemia and suggest potential therapeutic targets for human leukemia.<\/jats:p>","DOI":"10.1038\/s41598-019-41805-x","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T10:03:17Z","timestamp":1554199397000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Keith R.","family":"Loeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget T.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Fissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyka J.","family":"Osteen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue E.","family":"Knoblaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Grim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke J.","family":"Drury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Sarver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Clurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"41805_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ymeth.2009.07.002","volume":"49","author":"DA Largaespada","year":"2009","unstructured":"Largaespada, D. A. Transposon-mediated mutagenesis of somatic cells in the mouse for cancer gene identification. Methods 49, 282\u2013286, https:\/\/doi.org\/10.1016\/j.ymeth.2009.07.002 (2009).","journal-title":"Methods"},{"key":"41805_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.semcancer.2010.05.003","volume":"20","author":"AJ Dupuy","year":"2010","unstructured":"Dupuy, A. J. Transposon-based screens for cancer gene discovery in mouse models. Semin Cancer Biol 20, 261\u2013268, https:\/\/doi.org\/10.1016\/j.semcancer.2010.05.003 (2010).","journal-title":"Semin Cancer Biol"},{"key":"41805_CR3","doi-asserted-by":"publisher","first-page":"D844","DOI":"10.1093\/nar\/gku770","volume":"43","author":"KL Abbott","year":"2015","unstructured":"Abbott, K. L. et al. The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice. Nucleic Acids Res 43, D844\u2013848, https:\/\/doi.org\/10.1093\/nar\/gku770 (2015).","journal-title":"Nucleic Acids Res"},{"key":"41805_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nrc2916","volume":"10","author":"NG Copeland","year":"2010","unstructured":"Copeland, N. G. & Jenkins, N. A. Harnessing transposons for cancer gene discovery. Nat Rev Cancer 10, 696\u2013706, https:\/\/doi.org\/10.1038\/nrc2916 (2010).","journal-title":"Nat Rev Cancer"},{"key":"41805_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.gde.2015.04.007","volume":"30","author":"BS Moriarity","year":"2015","unstructured":"Moriarity, B. S. & Largaespada, D. A. Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery. Curr Opin Genet Dev 30, 66\u201372, https:\/\/doi.org\/10.1016\/j.gde.2015.04.007 (2015).","journal-title":"Curr Opin Genet Dev"},{"key":"41805_CR6","doi-asserted-by":"publisher","first-page":"D1011","DOI":"10.1093\/nar\/gkx956","volume":"46","author":"JY Newberg","year":"2018","unstructured":"Newberg, J. Y., Mann, K. M., Mann, M. B., Jenkins, N. A. & Copeland, N. G. SBCDDB: Sleeping Beauty Cancer Driver Database for gene discovery in mouse models of human cancers. Nucleic Acids Res 46, D1011\u2013D1017, https:\/\/doi.org\/10.1093\/nar\/gkx956 (2018).","journal-title":"Nucleic Acids Res"},{"key":"41805_CR7","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/sj.onc.1208613","volume":"24","author":"HC Hwang","year":"2005","unstructured":"Hwang, H. C. & Clurman, B. E. Cyclin E in normal and neoplastic cell cycles. Oncogene 24, 2776\u20132786 (2005).","journal-title":"Oncogene"},{"key":"41805_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1126\/science.1065203","volume":"294","author":"DM Koepp","year":"2001","unstructured":"Koepp, D. M. et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294, 173\u2013177 (2001).","journal-title":"Science"},{"key":"41805_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35095076","volume":"413","author":"H Strohmaier","year":"2001","unstructured":"Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316\u2013322 (2001).","journal-title":"Nature"},{"key":"41805_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/35095068","volume":"413","author":"KH Moberg","year":"2001","unstructured":"Moberg, K. H., Bell, D. W., Wahrer, D. C., Haber, D. A. & Hariharan, I. K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413, 311\u2013316 (2001).","journal-title":"Nature"},{"key":"41805_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1097-2765(03)00287-9","volume":"12","author":"M Welcker","year":"2003","unstructured":"Welcker, M. et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Molecular cell 12, 381\u2013392 (2003).","journal-title":"Molecular cell"},{"key":"41805_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ccell.2014.09.013","volume":"26","author":"RJ Davis","year":"2014","unstructured":"Davis, R. J., Welcker, M. & Clurman, B. E. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 26, 455\u2013464, https:\/\/doi.org\/10.1016\/j.ccell.2014.09.013 (2014).","journal-title":"Cancer Cell"},{"key":"41805_CR13","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1101\/gad.1650208","volume":"22","author":"AC Minella","year":"2008","unstructured":"Minella, A. C. et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes & development 22, 1677\u20131689 (2008).","journal-title":"Genes & development"},{"key":"41805_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2005.06.010","volume":"8","author":"K Loeb","year":"2005","unstructured":"Loeb, K. et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8, 35\u201347 (2005).","journal-title":"Cancer Cell"},{"key":"41805_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/genetics\/165.1.243","volume":"165","author":"CM Carlson","year":"2003","unstructured":"Carlson, C. M. et al. Transposon mutagenesis of the mouse germline. Genetics 165, 243\u2013256 (2003).","journal-title":"Genetics"},{"key":"41805_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nmeth795","volume":"2","author":"VW Keng","year":"2005","unstructured":"Keng, V. W. et al. Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nature methods 2, 763\u2013769, https:\/\/doi.org\/10.1038\/nmeth795 (2005).","journal-title":"Nature methods"},{"key":"41805_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature03691","volume":"436","author":"AJ Dupuy","year":"2005","unstructured":"Dupuy, A. J., Akagi, K., Largaespada, D. A., Copeland, N. G. & Jenkins, N. A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221\u2013226, https:\/\/doi.org\/10.1038\/nature03691 (2005).","journal-title":"Nature"},{"key":"41805_CR18","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1158\/0008-5472.CAN-09-1135","volume":"69","author":"AJ Dupuy","year":"2009","unstructured":"Dupuy, A. J. et al. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69, 8150\u20138156, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1135 (2009).","journal-title":"Cancer Res"},{"key":"41805_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","volume":"32","author":"P Boddu","year":"2018","unstructured":"Boddu, P. et al. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev 32, 96\u2013105, https:\/\/doi.org\/10.1016\/j.blre.2017.09.002 (2018).","journal-title":"Blood Rev"},{"key":"41805_CR20","doi-asserted-by":"publisher","first-page":"e24668","DOI":"10.1371\/journal.pone.0024668","volume":"6","author":"BT Brett","year":"2011","unstructured":"Brett, B. T. et al. Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PloS one 6, e24668, https:\/\/doi.org\/10.1371\/journal.pone.0024668 (2011).","journal-title":"PloS one"},{"key":"41805_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-154","volume":"13","author":"AL Sarver","year":"2012","unstructured":"Sarver, A. L., Erdman, J., Starr, T., Largaespada, D. A. & Silverstein, K. A. TAPDANCE: an automated tool to identify and annotate transposon insertion CISs and associations between CISs from next generation sequence data. BMC Bioinformatics 13, 154, https:\/\/doi.org\/10.1186\/1471-2105-13-154 (2012).","journal-title":"BMC Bioinformatics"},{"key":"41805_CR22","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1182\/blood-2011-03-343947","volume":"118","author":"KE Berquam-Vrieze","year":"2011","unstructured":"Berquam-Vrieze, K. E. et al. Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood 118, 4646\u20134656, https:\/\/doi.org\/10.1182\/blood-2011-03-343947 (2011).","journal-title":"Blood"},{"key":"41805_CR23","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-09-1760","volume":"69","author":"LS Collier","year":"2009","unstructured":"Collier, L. S. et al. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia\/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69, 8429\u20138437, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1760 (2009).","journal-title":"Cancer Res"},{"key":"41805_CR24","first-page":"7181","volume":"62","author":"S Wotton","year":"2002","unstructured":"Wotton, S. et al. Proviral insertion indicates a dominant oncogenic role for Runx1\/AML-1 in T-cell lymphoma. Cancer Res 62, 7181\u20137185 (2002).","journal-title":"Cancer Res"},{"key":"41805_CR25","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1073\/pnas.1304234110","volume":"110","author":"JZ Tang","year":"2013","unstructured":"Tang, J. Z. et al. Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 110, 6091\u20136096, https:\/\/doi.org\/10.1073\/pnas.1304234110 (2013).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"41805_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-10-2","volume":"10","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas. BMC Mol Biol 10, 2, https:\/\/doi.org\/10.1186\/1471-2199-10-2 (2009).","journal-title":"BMC Mol Biol"},{"key":"41805_CR27","doi-asserted-by":"publisher","first-page":"15437","DOI":"10.1073\/pnas.1213454109","volume":"109","author":"CL Carmichael","year":"2012","unstructured":"Carmichael, C. L. et al. Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 109, 15437\u201315442, https:\/\/doi.org\/10.1073\/pnas.1213454109 (2012).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"41805_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.biocel.2011.05.014","volume":"43","author":"JH Martens","year":"2011","unstructured":"Martens, J. H. Acute myeloid leukemia: a central role for the ETS factor ERG. Int J Biochem Cell Biol 43, 1413\u20131416, https:\/\/doi.org\/10.1016\/j.biocel.2011.05.014 (2011).","journal-title":"Int J Biochem Cell Biol"},{"key":"41805_CR29","doi-asserted-by":"publisher","unstructured":"Pigazzi, M. et al. Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. Blood 119, 1086\u20131087; author reply 1087\u20131088, https:\/\/doi.org\/10.1182\/blood-2011-10-385815 (2012).","DOI":"10.1182\/blood-2011-10-385815"},{"key":"41805_CR30","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/stem.2627","volume":"35","author":"Y Xie","year":"2017","unstructured":"Xie, Y. et al. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells. Stem Cells 35, 1773\u20131785, https:\/\/doi.org\/10.1002\/stem.2627 (2017).","journal-title":"Stem Cells"},{"key":"41805_CR31","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1182\/blood-2010-11-320515","volume":"117","author":"S Tsuzuki","year":"2011","unstructured":"Tsuzuki, S., Taguchi, O. & Seto, M. Promotion and maintenance of leukemia by ERG. Blood 117, 3858\u20133868, https:\/\/doi.org\/10.1182\/blood-2010-11-320515 (2011).","journal-title":"Blood"},{"key":"41805_CR32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1101\/gad.268409.115","volume":"29","author":"KJ Knudsen","year":"2015","unstructured":"Knudsen, K. J. et al. ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation. Genes & development 29, 1915\u20131929, https:\/\/doi.org\/10.1101\/gad.268409.115 (2015).","journal-title":"Genes & development"},{"key":"41805_CR33","doi-asserted-by":"publisher","first-page":"23572","DOI":"10.1074\/jbc.M101885200","volume":"276","author":"Y Parada","year":"2001","unstructured":"Parada, Y. et al. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. The Journal of biological chemistry 276, 23572\u201323580, https:\/\/doi.org\/10.1074\/jbc.M101885200 (2001).","journal-title":"The Journal of biological chemistry"},{"key":"41805_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.seminhematol.2015.03.004","volume":"52","author":"MR Grunwald","year":"2015","unstructured":"Grunwald, M. R. & Levis, M. J. FLT3 Tyrosine Kinase Inhibition as a Paradigm for Targeted Drug Development in Acute Myeloid Leukemia. Seminars in hematology 52, 193\u2013199, https:\/\/doi.org\/10.1053\/j.seminhematol.2015.03.004 (2015).","journal-title":"Seminars in hematology"},{"key":"41805_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1128\/MCB.17.1.453","volume":"17","author":"DM Bortner","year":"1997","unstructured":"Bortner, D. M. & Rosenberg, M. P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Molecular and cellular biology 17, 453\u2013459 (1997).","journal-title":"Molecular and cellular biology"},{"key":"41805_CR36","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1073\/pnas.0606537104","volume":"104","author":"Y Ma","year":"2007","unstructured":"Ma, Y. et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proceedings of the National Academy of Sciences of the United States of America 104, 4089\u20134094, https:\/\/doi.org\/10.1073\/pnas.0606537104 (2007).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"41805_CR37","doi-asserted-by":"publisher","first-page":"7245","DOI":"10.1038\/sj.onc.1209713","volume":"25","author":"AP Smith","year":"2006","unstructured":"Smith, A. P. et al. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland. Oncogene 25, 7245\u20137259, https:\/\/doi.org\/10.1038\/sj.onc.1209713 (2006).","journal-title":"Oncogene"},{"key":"41805_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.molcel.2006.11.029","volume":"25","author":"Y Geng","year":"2007","unstructured":"Geng, Y. et al. Kinase-independent function of cyclin E. Molecular cell 25, 127\u2013139 (2007).","journal-title":"Molecular cell"},{"key":"41805_CR39","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr, C. J. Cancer cell cycles. Science 274, 1672\u20131677 (1996).","journal-title":"Science"},{"key":"41805_CR40","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1126\/science.8384376","volume":"259","author":"M Ohtsubo","year":"1993","unstructured":"Ohtsubo, M. & Roberts, J. M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259, 1908\u20131912 (1993).","journal-title":"Science"},{"key":"41805_CR41","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405, https:\/\/doi.org\/10.1182\/blood-2016-03-643544 (2016).","journal-title":"Blood"},{"key":"41805_CR42","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini, E., Bacci, F., Sagramoso, C. & Pileri, S. A. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102, 83\u201387 (2010).","journal-title":"Pathologica"},{"key":"41805_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ajh.24626","volume":"92","author":"W Wang","year":"2017","unstructured":"Wang, W., Wang, S. A., Medeiros, L. J. & Khoury, J. D. Pure erythroid leukemia. Am J Hematol 92, 292\u2013296, https:\/\/doi.org\/10.1002\/ajh.24626 (2017).","journal-title":"Am J Hematol"},{"key":"41805_CR44","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1182\/blood-2016-11-749903","volume":"129","author":"G Montalban-Bravo","year":"2017","unstructured":"Montalban-Bravo, G. et al. More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood 129, 2584\u20132587, https:\/\/doi.org\/10.1182\/blood-2016-11-749903 (2017).","journal-title":"Blood"},{"key":"41805_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature02596","volume":"429","author":"A Muto","year":"2004","unstructured":"Muto, A. et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429, 566\u2013571, https:\/\/doi.org\/10.1038\/nature02596 (2004).","journal-title":"Nature"},{"key":"41805_CR46","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.18632\/oncotarget.14038","volume":"8","author":"Z Ge","year":"2017","unstructured":"Ge, Z. et al. Ikaros regulation of the BCL6\/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia. Oncotarget 8, 8022\u20138034, https:\/\/doi.org\/10.18632\/oncotarget.14038 (2017).","journal-title":"Oncotarget"},{"key":"41805_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1620\/tjem.232.229","volume":"232","author":"K Igarashi","year":"2014","unstructured":"Igarashi, K. & Watanabe-Matsui, M. Wearing red for signaling: the heme-bach axis in heme metabolism, oxidative stress response and iron immunology. Tohoku J Exp Med 232, 229\u2013253 (2014).","journal-title":"Tohoku J Exp Med"},{"key":"41805_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12016-016-8538-7","volume":"50","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y., Wu, H., Zhao, M., Chang, C. & Lu, Q. The Bach Family of Transcription Factors: A Comprehensive Review. Clin Rev Allergy Immunol 50, 345\u2013356, https:\/\/doi.org\/10.1007\/s12016-016-8538-7 (2016).","journal-title":"Clin Rev Allergy Immunol"},{"key":"41805_CR49","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41590-018-0202-3","volume":"19","author":"H Kato","year":"2018","unstructured":"Kato, H. et al. Infection perturbs Bach2- and Bach1-dependent erythroid lineage \u2018choice\u2019 to cause anemia. Nat Immunol 19, 1059\u20131070, https:\/\/doi.org\/10.1038\/s41590-018-0202-3 (2018).","journal-title":"Nat Immunol"},{"key":"41805_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V100.1.238","volume":"100","author":"SC Kogan","year":"2002","unstructured":"Kogan, S. C. et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100, 238\u2013245 (2002).","journal-title":"Blood"},{"key":"41805_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1182\/blood.V100.1.246","volume":"100","author":"HC Morse 3rd","year":"2002","unstructured":"Morse, H. C. 3rd et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246\u2013258 (2002).","journal-title":"Blood"},{"key":"41805_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cyto.b.21482","volume":"94","author":"S Cherian","year":"2018","unstructured":"Cherian, S. et al. A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia\/lymphoma post anti-CD19 therapy. Cytometry B Clin Cytom 94, 112\u2013120, https:\/\/doi.org\/10.1002\/cyto.b.21482 (2018).","journal-title":"Cytometry B Clin Cytom"},{"key":"41805_CR53","doi-asserted-by":"crossref","unstructured":"Minella, A. C., Grim, J. E., Welcker, M. & Clurman, B. E. p53 and SCF(Fbw7) cooperatively restrain cyclin E-associated genome instability. Oncogene (2007).","DOI":"10.1038\/sj.onc.1210518"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41805-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:28:18Z","timestamp":1671265698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41805-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41805"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41805-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5488"}}